Wealthfront Advisers LLC Maravai Lifesciences Holdings, Inc. Transaction History
Wealthfront Advisers LLC
- $120 Billion
- Q4 2024
A detailed history of Wealthfront Advisers LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Wealthfront Advisers LLC holds 191,900 shares of MRVI stock, worth $758,005. This represents 0.0% of its overall portfolio holdings.
Number of Shares
191,900Holding current value
$758,005% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MRVI
# of Institutions
203Shares Held
138MCall Options Held
271KPut Options Held
37.6K-
Gtcr LLC20.2MShares$79.6 Million10.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$46.7 Million0.0% of portfolio
-
12 West Capital Management LP New York, NY11.6MShares$45.8 Million6.99% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$38.4 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$33 Million2.55% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $520M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...